Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 10/20 | 0.32 |
| ▸ | DPP7 | Q9UHL4 | 7/20 | 0.32 |
| ▸ | FAP | Q12884 | 10/20 | 0.31 |
| ▸ | PREP | P48147 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3259037 | 0.74 | DPP4 (0.43) | DPP4DPP7FAPPREP | |
| SCHEMBL1237249 | 0.67 | — | — | |
| SCHEMBL987621 | 0.67 | DPP4 (0.66) | DPP4DPP7FAPPREP | |
| SCHEMBL3641383 | 0.67 | DPP4 (0.66) | DPP4DPP7FAPPREP | |
| Glycine SCHEMBL2309030 | 0.65 | DPP4 (0.41) | DPP4FAPPREP | |
| SCHEMBL341470 | 0.63 | SMN1; SMN2 (0.39) | DPP4DPP7 | |
| SCHEMBL3942505 | 0.61 | L3MBTL1 (0.36) | — | |
| SCHEMBL4077561 | 0.61 | ATM (0.48) | DPP4 | |
| SCHEMBL11724604 | 0.61 | L3MBTL1 (0.43) | DPP7 | |
| SCHEMBL2804280 | 0.60 | HSD17B10 (0.40) | DPP4PREP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8748457-B2 | 2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent DPP-IV inhibitors | LUPIN LIMITED (IN) | 2014-06-10 | — | — | US | disclosed |
| US-8338450-B2 | Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors | LUPIN LIMITED (IN) | 2012-12-25 | — | — | US | disclosed |
| US-8299271-B2 | Solid tartrate salts of DPP-IV inhibitors | PHENOMIX CORPORATION (US) | 2012-10-30 | — | — | US | disclosed |
| US-8299271-B2 | Solid tartrate salts of DPP-IV inhibitors | PHENOMIX CORPORATION (US) | 2012-10-30 | — | — | US | disclosed |
| US-20120082635-A1 | 2-AMINO-2- [8-(DIMETHYL CARBAMOYL)- 8-AZA- BICYCLO [3.2.1] OCT-3-YL]-EXO- ETHANOYL DERIVATIVES AS POTENT DPP-IV INHIBITORS | LUPIN LIMITED (IN) | 2012-04-05 | — | — | US | disclosed |
| US-7906658-B2 | Antidiabetic agents | PHENOMIX CORPORATION (US) | 2011-03-15 | — | — | US | disclosed |
| US-7884217-B2 | Antidiabetic agents | PHENOMIX CORPORATION (US) | 2011-02-08 | — | — | US | disclosed |
| US-7884217-B2 | Antidiabetic agents | PHENOMIX CORPORATION (US) | 2011-02-08 | — | — | US | disclosed |
| US-20100323988-A1 | SOLID CITRATE AND TARTRATE SALTS OF DPP-IV INHIBITORS | PHENOMIX CORPORATION (US) | 2010-12-23 | — | — | US | disclosed |
| WO-2010146597-A1 | 2-AMINO-2- [8-(DIMETHYL CARBAMOYL)- 8-AZA- BICYCLO [3.2.1] OCT-3-YL]-EXO- ETHANOYL DERIVATIVES AS POTENT DPP-IV INHIBITORS | LUPIN LIMITED (IN) | 2010-12-23 | — | — | WO | disclosed |
| WO-2008027273-A2 | SOLID CITRATE AND TARTRATE SALTS OF DPP-IV INHIBITORS | PHENOMIX CORPORATION (US) | 2008-03-06 | — | — | WO | disclosed |
| WO-2008027273-A2 | SOLID CITRATE AND TARTRATE SALTS OF DPP-IV INHIBITORS | PHENOMIX CORPORATION (US) | 2008-03-06 | — | — | WO | disclosed |
| US-7317109-B2 | Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV | PHENOMIX CORPORATION (US) | 2008-01-08 | — | — | US | disclosed |
| US-7317109-B2 | Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV | PHENOMIX CORPORATION (US) | 2008-01-08 | — | — | US | disclosed |
| US-20070299036-A1 | PYRROLIDINE COMPOUNDS AND METHODS FOR SELECTIVE INHIBITION OF DIPEPTIDYL PEPTIDASE-IV | PHENOMIX CORPORATION | 2007-12-27 | — | — | US | disclosed |
| US-20060264401-A1 | METHYL AND ETHYL SUBSTITUTED PYRROLIDINE COMPOUNDS AND METHODS FOR SELECTIVE INHIBITION OF DIPEPTIDYL PEPTIDASE-IV | PHENOMIX CORPORATION | 2006-11-23 | — | — | US | disclosed |
| US-20060264400-A1 | PYRROLIDINE COMPOUNDS AND METHODS FOR SELECTIVE INHIBITION OF DIPEPTIDYL PEPTIDASE-IV | SINO-MED INTERNATIONAL ALLIANCE, INC. | 2006-11-23 | — | — | US | disclosed |
| US-20060264400-A1 | PYRROLIDINE COMPOUNDS AND METHODS FOR SELECTIVE INHIBITION OF DIPEPTIDYL PEPTIDASE-IV | SINO-MED INTERNATIONAL ALLIANCE, INC. | 2006-11-23 | — | — | US | disclosed |
| US-20060258621-A1 | PYRROLIDINE COMPOUNDS AND METHODS FOR SELECTIVE INHIBITION OF DIPEPTIDYL PEPTIDASE-IV | SINO-MED INTERNATIONAL ALLIANCE, INC. | 2006-11-16 | — | — | US | disclosed |
| US-20060258621-A1 | PYRROLIDINE COMPOUNDS AND METHODS FOR SELECTIVE INHIBITION OF DIPEPTIDYL PEPTIDASE-IV | SINO-MED INTERNATIONAL ALLIANCE, INC. | 2006-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264400-A1 | PYRROLIDINE COMPOUNDS AND METHODS FOR SELECTIVE INHIBITION OF DIPEPTIDYL PEPTIDASE-IV | DPP4, DPP7, DPP3 | DPP4 1/4885DPP7 2/4885FAP 22/4885 |
| US-20100323988-A1 | SOLID CITRATE AND TARTRATE SALTS OF DPP-IV INHIBITORS | DPP4, DPP3, DPP7 | DPP4 1/4885DPP7 3/4885FAP 142/4885 |
| US-20060258621-A1 | PYRROLIDINE COMPOUNDS AND METHODS FOR SELECTIVE INHIBITION OF DIPEPTIDYL PEPTIDASE-IV | DPP4, DPP7, DPP3 | DPP4 1/4885DPP7 2/4885FAP 24/4885 |
| US-20120082635-A1 | 2-AMINO-2- [8-(DIMETHYL CARBAMOYL)- 8-AZA- BICYCLO [3.2.1] OCT-3-YL]-EXO- ETHANOYL DERIVATIVES AS POTENT DPP-IV INHIBITORS | DPP7, DPP4, DPP8 | DPP4 2/4885DPP7 1/4885FAP 247/4885 |
| US-20060264401-A1 | METHYL AND ETHYL SUBSTITUTED PYRROLIDINE COMPOUNDS AND METHODS FOR SELECTIVE INHIBITION OF DIPEPTIDYL PEPTIDASE-IV | DPP4, DPP3, DPP7 | DPP4 1/4885DPP7 3/4885FAP 28/4885 |
| US-20070299036-A1 | PYRROLIDINE COMPOUNDS AND METHODS FOR SELECTIVE INHIBITION OF DIPEPTIDYL PEPTIDASE-IV | DPP4, DPP7, DPP3 | DPP4 1/4885DPP7 2/4885FAP 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.